Adalimumab 43835-0035-01
- Manufacturer
- Novo Nordisk Production Belgium Sa
- Dosage Form
- Injection
- Product Type
- Drug For Further Processing
- Marketing Start
- July 1, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Adalimumab-Bwwd | 100 mg/mL |
Selected Package
43835-0035-01Selected224 SYRINGE in 1 BOX (43835-0035-1) / .4 mL in 1 SYRINGE
Other packages for this product(1)
170 SYRINGE in 1 BOX (43835-0035-2) / .4 mL in 1 SYRINGE